# BriaCell Therapeutics Corp. (BCTX)

> Healthcare · CA · Reports in CAD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/BCTX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -14.52M | $ -15.17M | $ 0 | $ 24.06M |
| 2025 | $ 0 | $ -40.28M | $ -40.55M | $ 0 | $ 9.98M |
| 2024 | $ 0 | $ -23.03M | $ -33.17M | $ 0 | $ 5.63M |
| 2023 | $ 0 | $ -18.19M | $ -38.86M | $ 0 | $ 3.74M |
| 2022 | $ 0 | $ -21.86M | $ -18.60M | $ 0 | $ 14.03M |
| 2021 | $ 0 | $ -39.61M | $ -13.26M | $ 33.3K | $ 68.48M |
| 2020 | $ 0 | $ -3.56M | $ -680.1K | $ 258.8K | $ -3.37M |
| 2019 | $ 0 | $ -5.96M | $ -5.86M | $ 0 | $ -816.3K |
| 2018 | $ 0 | $ -5.52M | $ -6.06M | $ 825.4K | $ 361.7K |
| 2017 | $ 0 | $ -3.48M | $ -3.51M | $ 0 | $ 987.4K |
| 2016 | $ 0 | $ -2.07M | $ -2.06M | $ 0 | $ 1.61M |
| 2015 | $ 0 | $ -3.66M | $ -1.57M | $ 0 | $ 873.3K |
| 2014 | $ 0 | $ -10.63M | $ -765.5K | $ 0 | $ 609.6K |
| 2013 | $ 0 | $ -593.8K | $ -945.7K | $ 0 | $ 9.10M |
| 2012 | $ 0 | $ -1.27M | $ -2.98M | $ 0 | $ 9.96M |
| 2011 | $ 0 | $ -1.49M | $ -2.45M | $ 0 | $ 11.02M |
| 2010 | $ 0 | $ -1.32M | $ -1.11M | $ 0 | $ 1.38M |
| 2009 | $ 0 | $ -338.0K | $ -289.6K | $ 0 | $ 914.3K |
| 2008 | $ 0 | $ -207.3K | $ -234.6K | $ 0 | $ 264.2K |
| 2007 | $ 0 | $ -130.6K | $ -100.0K | $ 0 | $ 496.2K |
| 2006 | $ 0 | $ -42.8K | $ -39.4K | $ 0 | $ 469.8K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.15 |
| Current Ratio | 7.07 |

## Other views

- [Metrics](https://sponda.capital/en/BCTX.md)
- [Charts](https://sponda.capital/en/BCTX/charts.md)
- [Compare](https://sponda.capital/en/BCTX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.